Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine

被引:9
|
作者
Matar, Abraham J. [1 ,2 ]
Patil, Aarti R. [1 ]
Al-Musa, Ahmad [1 ]
Hanekamp, Isabel [1 ]
Sachs, David H. [1 ]
Huang, Christene A. [1 ]
Duran-Struuck, Raimon [1 ,3 ]
机构
[1] Massachusetts Gen Hosp, Dept Surg, Transplantat Biol Res Ctr, Boston, MA 02114 USA
[2] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA
[3] Columbia Univ, Columbia Ctr Translat Immunol, New York, NY USA
基金
美国国家卫生研究院;
关键词
Hematopoietic cell transplantation; Post-transplant lymphoproliferative disease; EPSTEIN-BARR-VIRUS; LARGE-ANIMAL-MODEL; PREPARATIVE REGIMEN; MIXED CHIMERISM; CD3; IMMUNOTOXIN; BONE-MARROW; SCID MICE; IN-VIVO; DISEASE;
D O I
10.1016/j.bbmt.2015.07.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-transplant lymphoproliferative disease (PTLD) is a major complication of clinical organ and cell transplantation. Conditioning and immunosuppressive regimens that significantly impair T cell immunity, including depleting antibodies and calcineurin inhibitors, increase the risk of PTLD after transplantation. Swine PTLD has been shown to closely resemble human PTLD in morphology, histology, and viral-driven reactivation of B cells. Previously, we reported high incidences of PTLD after hematopoietic cell transplantation (HCT) in miniature swine recipients conditioned with thymic irradiation (TI) in addition to T cell depletion and cyclosporine A monotherapy after transplantation. Replacement of TI with 100 cGy of total body irradiation resulted in similar numbers of B cells early post-transplantation, greater numbers of T cells at day 0, and markedly decreased incidence of PTLD, suggesting that a threshold number of T cells may be necessary to prevent subsequent B cell proliferation and development of overt PTLD. Results from this large cohort of animals provide insight into the important effect of irradiation and T cell immunity on the incidence of PTLD after HCT and reinforce the pig model as a valuable tool for the study of PTLD and HCT. (C) 2015 American Society for Blood and Marrow Transplantation.
引用
收藏
页码:1732 / 1738
页数:7
相关论文
共 50 条
  • [1] Risk Factors for the Incidence of and the Mortality due to Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation
    Kinzel, Megan
    Dowhan, Michelle
    Kalra, Amit
    Williamson, Tyler S.
    Dabas, Rosy
    Jamani, Kareem
    Chaudhry, Ahsan
    Shafey, Mona
    Jimenez-Zepeda, Victor
    Duggan, Peter
    Daly, Andrew
    Dharmani-Khan, Poonam
    Khan, Faisal
    Storek, Jan
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 53.e1 - 53.e10
  • [2] Burden of Post-Transplant Lymphoproliferative Disorder-Mortality After Allogeneic Hematopoietic Cell Transplantation
    Katz, Aaron
    Barlev, Arie
    Joshi, A. J.
    BONE MARROW TRANSPLANTATION, 2018, 53 : 305 - 306
  • [3] Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation
    Yoon, Jae-Ho
    Lee, Seok
    Kim, Hee-Je
    Lee, Jong-Wook
    Min, Woo-Sung
    Chung, Byung Ha
    Yang, Chul Woo
    Kim, Yong-Soo
    Kim, Ji-Il
    Moon, In Sung
    Oh, Eun Ji
    Park, Gyeong-Sin
    Cho, Seok-Goo
    TRANSPLANT INTERNATIONAL, 2014, 27 (07) : 721 - 732
  • [4] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION
    Fiskvik, I.
    Bentdal, O.
    Holdaas, H.
    Leivestad, T.
    Grotmol, T.
    Holte, H.
    HAEMATOLOGICA, 2014, 99 : 708 - 708
  • [5] POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION
    Fiskvik, Idun
    Holte, Harald
    Bentdal, Oystein
    Holdaas, Hallvard
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 556 - 557
  • [6] Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation
    Kalra, Amit
    Roessner, Cameron
    Jupp, Jennifer
    Williamson, Tyler
    Tellier, Raymond
    Chaudhry, Ahsan
    Khan, Faisal
    Taparia, Minakshi
    Jimenez-Zepeda, Victor H.
    Stewart, Douglas A.
    Daly, Andrew
    Storek, Jan
    CLINICAL TRANSPLANTATION, 2018, 32 (01)
  • [7] Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation
    Ohta, Hideaki
    Fukushima, Norihide
    Ozono, Keiichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (02) : 127 - 136
  • [8] Risk Factors and Predictive Scoring System For Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation
    Fujimoto, Ayumi
    Hiramoto, Nobuhiro
    Yamasaki, Satoshi
    Inamoto, Yoshihiro
    Uchida, Naoyuki
    Maeda, Tetsuo
    Mori, Takehiko
    Kande, Yoshinobu
    Kondo, Tadakazu
    Shiratori, Souichi
    Miyakoshi, Shigesaburo
    Ishiyama, Ken
    Ikegame, Kazuhiro
    Matsuhashi, Yoshiko
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Ogata, Masao
    Suzuki, Ritsuro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1441 - 1449
  • [9] Post-transplant lymphoproliferative disorder after paediatric liver transplantation
    Liu, Ying
    Sun, Li-Ying
    Zhu, Zhi-jun
    Wei, Lin
    Qu, Wei
    Wang, Lin
    Yuan, Lei-lei
    Zeng, Zhi-Gui
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [10] EBV-associated post-transplant lymphoproliferative disorder after pediatric allogeneic hematopoietic stem cell transplantation
    Yoo, Keen Hee
    Kim, Hee-Jin
    Ki, Chang Seok
    Sung, Ki Woong
    Jung, Hye Lim
    Ko, Youn Hyeh
    Koo, Hong-Hoe
    BLOOD, 2007, 110 (11) : 322B - 322B